CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-04 | Patel Sanj K CHAIRMAN & CEO | Grant or award · Performance Share Unit | +20,000 | 20,000 | ||
| 2024-04-04 | Patel Sanj K CHAIRMAN & CEO | Grant or award · Restricted Share Unit | +24,950 | 44,393 | ||
| 2024-04-04 | Paolini John F. CHIEF MEDICAL OFFICER | Grant or award · Share Option | +36,350 | 36,350 | ||
| 2024-04-04 | Paolini John F. CHIEF MEDICAL OFFICER | Grant or award · Performance Share Unit | +5,600 | 5,600 | ||
| 2024-04-04 | Paolini John F. CHIEF MEDICAL OFFICER | Grant or award · Restricted Share Unit | +7,000 | 11,872 | ||
| 2024-04-04 | Ragosa Mark CHIEF FINANCIAL OFFICER | Grant or award · Share Option | +33,150 | 33,150 | ||
| 2024-04-04 | Ragosa Mark CHIEF FINANCIAL OFFICER | Grant or award · Performance Share Unit | +5,092 | 5,092 | ||
| 2024-04-04 | Ragosa Mark CHIEF FINANCIAL OFFICER | Grant or award · Restricted Share Unit | +6,365 | 11,615 | ||
| 2024-04-04 | Moat Ross CHIEF COMMERCIAL OFFICER | Grant or award · Share Option | +36,100 | 36,100 | ||
| 2024-04-04 | Moat Ross CHIEF COMMERCIAL OFFICER | Grant or award · Performance Share Unit | +5,569 | 5,569 | ||
| 2024-04-04 | Moat Ross CHIEF COMMERCIAL OFFICER | Grant or award · Restricted Share Unit | +6,962 | 11,795 | ||
| 2024-04-04 | Megna Michael R CHIEF ACCOUNTING OFFICER | Grant or award · Share Option | +18,900 | 18,900 | ||
| 2024-04-04 | Megna Michael R CHIEF ACCOUNTING OFFICER | Grant or award · Restricted Share Unit | +9,450 | 17,122 | ||
| 2024-04-04 | Tessari Eben CHIEF OPERATING OFFICER | Grant or award · Share Option | +36,300 | 36,300 | ||
| 2024-04-04 | Tessari Eben CHIEF OPERATING OFFICER | Grant or award · Performance Share Unit | +5,585 | 5,585 | ||
| 2024-04-04 | Tessari Eben CHIEF OPERATING OFFICER | Grant or award · Restricted Share Unit | +6,981 | 12,299 | ||
| 2024-04-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise | +1,750 | 17,382 | ||
| 2024-04-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −514 | $19.70 | $10K | 16,868 |
| 2024-04-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Restricted Share Unit | −1,750 | 5,250 | ||
| 2024-04-01 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise | +1,773 | 124,620 |
Page 53 of 74 · 1,467 trades